Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase
Bernard Barlaam, David G. Acton, Peter Ballard, Robert H. Bradbury, Darren Cross, Richard Ducray, Hervé Germain, Kevin Hudson, Teresa Klinowska, Françoise Magnien, Donald J. Ogilvie, Annie Olivier, HeVolume:
18
Year:
2008
Language:
english
Pages:
5
DOI:
10.1016/j.bmcl.2008.02.035
File:
PDF, 182 KB
english, 2008